Comparison of recombinant cell bioassays for the detection of Ah receptor agonists
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
In this study, we have compared the time and dose response curves for TCDD using the pGudLuc1.1‐chemically activated luciferase expression (CALUX) cell bioassay and two new recombinant cell lines that contain a stably transfected mutated form of firefly luciferase reporter gene (pGudLuc6.1) or enhanced green fluorescent protein (EGFP) reporter gene (pGreen1.1). The time course of induction with pGudLuc1.1‐containing H1L1.1c2 cells is transient, with maximal activity observed at 4 hours after treatment with 1 nM TCDD. In contrast, expression of luciferase from the pGudLuc6.1‐containing H1L6.1c2 cells and the pGreen1.1‐containing H1G1.1c3 cells progressively increases with time, with luciferase activity increasing at a significant faster rate than that of EGFP. Dose response analysis with each cell line at optimal analysis times reveal similar relative dose response curves and EC 50 s for H1L6.1c2 and H1G1.1c3 cells, while the EC 50 for TCDD in the H1L1.1c2 cells was about 7‐fold lower. In addition, these bioassay systems respond to halogenated and/or polycyclic aromatic hydrocarbons in a dose‐specific manner. Given the above differences between cell lines and reporters, the choice of which cell line to use will certainly be dependent on the specific questions and issues being examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895 · cited 1×
“High affinity ligands for the AhR include a variety of HAHs such as polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls, as well as numerous polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene, 3-methylchlolanthrene, benzoflavones, and other chemicals [8,10,33,37].”
BackgroundSelf-citationSafe, S. (1990) · Critical Reviews in Toxicology · doi:10.3109/10408449009089873 · Cited by 1,871
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · cited 2×
“Mechanistically, the AhR functions in a manner similar to that of the steroid hormone receptors, although they are clearly members of distinct families of transcription factors [1,17,39].”
BackgroundAH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899 · cited 1×
“Mechanistically, the AhR functions in a manner similar to that of the steroid hormone receptors, although they are clearly members of distinct families of transcription factors [1,17,39].”
BackgroundMimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.1490345.x · Cited by 626
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215
Probst, M. R., Reisz-Porszasz, S., Agbunag, R. V., Ong, M. S., & Hankinson, O. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13218-5 · Cited by 214
Cited by
Ahn, K. C., Zhao, B., Chen, J., Cherednichenko, G., Sanmarti, E., Denison, M. S., Lasley, B., Pessah, I. N., Kültz, D., Chang, D. P. Y., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11200 · Cited by 355
Self-citationCH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
Zhao, B., DeGroot, D. E., Hayashi, A., He, G., & Denison, M. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq217 · Cited by 312
Self-citationTrace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
Seok, S.-H., Ma, Z.-X., Feltenberger, J. B., Chen, H., Chen, H., Scarlett, C., Lin, Z., Satyshur, K. A., Cortopassi, M., Jefcoate, C. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000631 · Cited by 157
“1 DREs-driven luciferase reporter vector (14 ng) (30) and TK-Renilla luciferase vector (3 ng) (Invitrogen).”
BackgroundMethodNew Aryl Hydrocarbon Receptor Homology Model Targeted To Improve Docking Reliability
Motto, I., Bordogna, A., Soshilov, A. A., Denison, M. S., & Bonati, L. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2001617 · Cited by 80
Self-citationIdentification of the Ah-Receptor Structural Determinants for Ligand Preferences
Xing, Y., Nukaya, M., Satyshur, K. A., Jiang, L., Stanevich, V., Korkmaz, E. N., Burdette, L., Kennedy, G. D., Cui, Q., & Bradfield, C. A. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs194 · Cited by 67
“DREs-driven luciferase reporter vector (100 ng) (Han et al., 2004) and TK-renilla luciferase”
Background
Metadata
- Authors
- Han, D., Nagy, S. R., & Denison, M. S.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 20
- Issue
- 1
- Pages
- 11-22
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W2146264973
- Cited by
- 114
- References
- 9
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. https://app.cochat.ai/papers/10.1002/biof.5520200102
- The paper
- Han, D., Nagy, S. R., & Denison, M. S. (2004). Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. BioFactors. https://doi.org/10.1002/biof.5520200102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.